You are here

SLL

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?

Fierce Pharma

Bristol Myers Squibb

clinical trials

Flag link:

AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise

AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise

Endpoints

Flag link:

AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia

AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia

BioSpace

Flag link:

AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL

AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL

Pharmaceutical Business Review

Flag link:

Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL

Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL

BioCentury

priority review

Flag link: